Literature DB >> 19682426

A label-free mass spectrometry method for the quantification of protein isotypes.

Robert D Winefield1, Todd D Williams, Richard H Himes.   

Abstract

Successful quantitative mass spectrometry (MS) requires strategies to link the mass spectrometer response to the analyte abundance, with the response being dependent on more factors than just analyte abundance. Label-dependent strategies rely on the incorporation of an isotopically labeled internal standard into the sample. Current label-free strategies (performed without internal standards) are useful for analyzing samples that are unsuitable for isotopic labeling but are less accurate. Here we describe a label-free technique applicable to analysis of products from related genes (isotypes). This approach enables the invariant tryptic peptide sequences within the family to serve as "built-in" internal standards and the isotype-specific peptide sequences to report the amount of the various isotypes. A process of elimination segregates reliably trypsin-released standard and reporter peptides from unreliably released peptides. The specific MS response factors for these reporter and standard peptides can be determined using synthetic peptides. Analysis of HeLa tubulin digests revealed peptides from betaI-, betaII-, betaIII-, betaIVb-, and betaV-tubulin, eight of which were suitable; along with five standard peptides for quantification of the beta-tubulin isotypes. To show the utility of this method, we determined that betaI-tubulin represented 77% and betaIII-tubulin represented 3.2% of the total HeLa beta-tubulin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682426      PMCID: PMC3711517          DOI: 10.1016/j.ab.2009.07.052

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  37 in total

Review 1.  The role of beta-tubulin isotypes in resistance to antimitotic drugs.

Authors:  C A Burkhart; M Kavallaris; S Band Horwitz
Journal:  Biochim Biophys Acta       Date:  2001

Review 2.  Mass spectrometry-based proteomics.

Authors:  Ruedi Aebersold; Matthias Mann
Journal:  Nature       Date:  2003-03-13       Impact factor: 49.962

3.  Intrinsically slow dynamic instability of HeLa cell microtubules in vitro.

Authors:  Cori N Newton; Jennifer G DeLuca; Richard H Himes; Herbert P Miller; Mary Ann Jordan; Leslie Wilson
Journal:  J Biol Chem       Date:  2002-08-30       Impact factor: 5.157

4.  Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry.

Authors:  Pavel V Bondarenko; Dirk Chelius; Thomas A Shaler
Journal:  Anal Chem       Date:  2002-09-15       Impact factor: 6.986

5.  Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry.

Authors:  Dirk Chelius; Pavel V Bondarenko
Journal:  J Proteome Res       Date:  2002 Jul-Aug       Impact factor: 4.466

6.  Class III beta-tubulin expression in tumor cells is correlated with resistance to docetaxel in patients with completely resected non-small-cell lung cancer.

Authors:  Yoshiki Hayashi; Hideyuki Kuriyama; Hajime Umezu; Junta Tanaka; Tatsuya Yoshimasu; Tomoko Furukawa; Hiroshi Tanaka; Hiroshi Kagamu; Fumitake Gejyo; Hirohisa Yoshizawa
Journal:  Intern Med       Date:  2009-02-16       Impact factor: 1.271

Review 7.  Class III beta-tubulin in human development and cancer.

Authors:  Christos D Katsetos; Mary M Herman; Sverre J Mörk
Journal:  Cell Motil Cytoskeleton       Date:  2003-06

Review 8.  Ixabepilone: targeting betaIII-tubulin expression in taxane-resistant malignancies.

Authors:  Charles Dumontet; Mary Ann Jordan; Francis F Y Lee
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

Review 9.  Tubulin proteomics: towards breaking the code.

Authors:  Pascal Verdier-Pinard; Eddy Pasquier; Hui Xiao; Berta Burd; Claude Villard; Daniel Lafitte; Leah M Miller; Ruth H Angeletti; Susan Band Horwitz; Diane Braguer
Journal:  Anal Biochem       Date:  2008-09-18       Impact factor: 3.365

10.  The taccalonolides: microtubule stabilizers that circumvent clinically relevant taxane resistance mechanisms.

Authors:  April L Risinger; Evelyn M Jackson; Lisa A Polin; Gregory L Helms; Desiree A LeBoeuf; Patrick A Joe; Elizabeth Hopper-Borge; Richard F Ludueña; Gary D Kruh; Susan L Mooberry
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more
  4 in total

1.  A label-free mass spectrometry method for relative quantitation of β-tubulin isotype expression in human tumor tissue.

Authors:  Leah M Miller; Chia-Ping Huang Yang; Hui Xiao; Sylvie Isaac; Pascal Sève; Charles Dumontet; Susan Band Horwitz; Ruth Hogue Angeletti
Journal:  Proteomics Clin Appl       Date:  2012-10       Impact factor: 3.494

Review 2.  Methods in tubulin proteomics.

Authors:  Leah M Miller; Hui Xiao; Berta Burd; Susan Band Horwitz; Ruth Hogue Angeletti; Pascal Verdier-Pinard
Journal:  Methods Cell Biol       Date:  2010       Impact factor: 1.441

3.  Regulation of highly homologous major urinary proteins in house mice quantified with label-free proteomic methods.

Authors:  Viktoria M Enk; Christian Baumann; Michaela Thoß; Kenneth C Luzynski; Ebrahim Razzazi-Fazeli; Dustin J Penn
Journal:  Mol Biosyst       Date:  2016-07-28

4.  Two predominant MUPs, OBP3 and MUP13, are male pheromones in rats.

Authors:  Xiao Guo; Huifen Guo; Lei Zhao; Yao-Hua Zhang; Jian-Xu Zhang
Journal:  Front Zool       Date:  2018-02-23       Impact factor: 3.172

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.